PATENT CLAIM ANALYSIS

Application Number: 16081896
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "469000"]

Abstract:
The present invention provides a parenteral dosage form consisting essentially of a solution filled in a container, the solution comprising amiodarone or its pharmaceutically acceptable salt and a sulfo-alkyl ether beta-cyclodextrin in an aqueous vehicle, wherein the solution has a pH in the range of about 2.4 to 3.9 and further wherein the dosage form is sterilized by subjecting the filled container to autoclaving.

Claim (Index 2):
A parenteral dosage form as claimed in  claim 1 , wherein the sulfoalkyl-ether beta-cyclodextrin is sulfobutyl-ether beta-cyclodextrin.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.45652
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15490314', '10139620', '14859733', '13871438', '12647841']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.740137944765743
- 35 USC 102 Novelty (BERT): 0.4889903045843284
- Combined Prediction Score: 0.7150231807476015
- Mean Citation Score: 126.2462562
- Max Citation Score: 150.93901
- Similarity Product: 96.9283079358953

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test